CIK 0000034956 · Non-accelerated filer<br>Smaller reporting company
TENAX THERAPEUTICS, INC.
Sign in to watch- Ticker
- TENX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262593535
- Phone
- 919-855-2100
- Business address
- 101 GLEN LENNOX DRIVE, SUITE 300, CHAPEL HILL, NC, 27517
- Former names
- OXYGEN BIOTHERAPEUTICS, INC., SYNTHETIC BLOOD INTERNATIONAL INC
- Open-market buys, last 90 days
- $6,396,312
- in 7 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$6,396,312. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-07-31 | Jebsen Michael B CFO | Returned to the company | +49 | $3.68 | $180 | 68,084 |
| 2015-05-15 | Jebsen Michael B CFO | Returned to the company | +430 | $3.42 | $1K | 68,133 |
| 2015-05-15 | Jebsen Michael B CFO | Returned to the company | +55 | $3.44 | $189 | 67,703 |
| 2015-02-13 | Jebsen Michael B CFO | Returned to the company | +56 | $3.28 | $184 | 67,758 |
| 2015-01-20 | BLANCK RONALD R Director | Purchase | +2,000 | $3.49 | $7K | 10,199 |
| 2014-10-31 | Jebsen Michael B CFO | Returned to the company | +49 | $3.94 | $193 | 67,814 |
| 2014-07-31 | Jebsen Michael B CFO | Returned to the company | +50 | $3.91 | $196 | 67,863 |
| 2014-07-15 | Jebsen Michael B Chief Financial Officer | Returned to the company | +14,761 | $4.67 | $69K | 67,483 |
| 2014-05-01 | Jebsen Michael B Chief Finanacial Officer | Grant or award | +430 | $4.98 | $2K | 67,913 |
| 2014-04-15 | Jebsen Michael B Chief Financial Officer | Returned to the company | +15 | $5.55 | $83 | 82,244 |
| 2014-03-15 | Jebsen Michael B President and CFO | Returned to the company | +16 | $6.47 | $104 | 82,259 |
| 2014-02-15 | Jebsen Michael B Chief Financial Officer | Returned to the company | +16 | $6.18 | $99 | 50,132 |
| 2014-01-15 | Jebsen Michael B Chief Financial Officer | Returned to the company | +16 | $4.50 | $72 | 50,148 |
| 2013-12-15 | Jebsen Michael B Chief Financial Officer | Returned to the company | +14 | $6.27 | $88 | 50,164 |
| 2013-11-15 | Jebsen Michael B Chief Financial Officer | Returned to the company | +14 | $3.04 | $43 | 50,178 |
| 2013-11-13 | Jebsen Michael B Chief Financial Officer | Grant or award | +32,143 | $7.00 | $225K | 82,335 |
| 2013-11-13 | Kelley John P Chief Executive Officer | Grant or award | +341,711 | 341,711 | ||
| 2013-11-13 | Kelley John P Chief Executive Officer | Grant or award | +8,248 | 8,248 | ||
| 2013-10-15 | Jebsen Michael B Chief Financial Officer | Returned to the company | +14 | $1.47 | $21 | 50,192 |
| 2013-10-04 | Jebsen Michael B Chief Financial Officer | Grant or award | +79,546 | $1.32 | $105K | 50,206 |
Page 10 of 16 · 316 trades